Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Leptomeningeal Disease
100%
Tumor Subtype
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
70%
Intrathecal Drug Delivery
30%
Hormone Receptor-positive
30%
Systemic Therapy
30%
Overall Survival
20%
Breast Cancer Subtypes
20%
Triple Negative
20%
Tumor
10%
Treatment Strategy
10%
Clinical Outcomes
10%
Clinical Features
10%
Patients with Breast Cancer
10%
Worse Outcome
10%
Median Overall Survival
10%
Effective Treatment
10%
Triple-negative Breast Cancer
10%
Extracranial
10%
Disease Therapy
10%
Kaplan-Meier Method
10%
Log-rank Test
10%
Old Age
10%
Cox Proportional Hazards
10%
Survival Disparities
10%
Leptomeninges
10%
Negative Breast Cancer
10%
Human Epidermal Growth Factor Receptor 2-negative
10%
Dismal Prognosis
10%
Medicine and Dentistry
Diseases
100%
Neoplasm
100%
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
54%
Gamma Urogastrone
54%
Systemic Therapy
27%
Overall Survival
27%
Hormone Receptor
27%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
18%
Combination Therapy
9%
Kaplan Meier Method
9%
Clinical Feature
9%
Log Rank Test
9%
Triple Negative Breast Cancer
9%
Leptomeninx
9%
Tumor
9%
Effective Treatment
9%
Neuroscience
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Hormone Receptor
37%
Intrathecal
37%
Leptomeninx
12%